P2X Receptors as Therapeutic Opportunity an EU COST Action. Understanding the role of P2XRs in inflammatory, infectious, neurologic and oncologic diseases and fostering the development of P2XR-targeting therapies.
The first #PRESTO cost meeting has made the local news! read more here: https://www.ferraratoday.it/cronaca/presto-meeting-progetto-europeo-dedicato-studio-nuovi-farmaci-contro-malattie-degenerative.html #prestocost2023 #P2X
COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.